Paper
Successful treatment with guanfacine in a long‐COVID case manifesting marked cognitive impairment
Published Jun 27, 2024 · Tsuyoshi Kondo, Riki Higa, Mariko Kuniba
Neuropsychopharmacology Reports
1
Citations
0
Influential Citations
Abstract
Persistent cognitive impairment is a serious consequence of the post‐COVID condition. However, there have been no established effective treatments for this pathophysiology supported by sufficient evidence.
Case Report
Study Snapshot
Guanfacine treatment significantly improved cognitive functioning and frontotemporal brain activity in long-COVID patients with apparent cognitive impairment.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···